Research Report on the Recombinant Human Thrombin Industry Market in China

With the emergence of a new generation of hemostatic drugs, the local hemostatic medication market for surgical procedures has undergone significant changes in recent years. Among them, recombinant human thrombin, as a new generation of local hemostatic products for surgical procedures, has received much market attention in recent years. Based on its understanding of this market, Frost & Sullivan (Frost & Sullivan) has released a market research report on the recombinant human thrombin industry in China. The report includes the clinical value of recombinant human thrombin, clinical practice of local surgical medication, market segmentation, competitive landscape, as well as historical statistics and future forecasts of the market size for this sub-market by Frost & Sullivan.